Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Front Cell Infect Microbiol ; 14: 1439476, 2024.
Article in English | MEDLINE | ID: mdl-39119296

ABSTRACT

Objective: Sclerodermus wasps are important biocontrol agents of a class of wood borers. Bacterial symbionts influence the ecology and biology of their hosts in a variety of ways, including the formation of life-long beneficial or detrimental parasitic infections. However, only a few studies have explored the species and content of the symbionts in the Sclerodermus species. Methods: Here, a high-throughput sequencing study of the V3-V4 region of the 16S ribosomal RNA gene revealed a high level of microbial variety in four Sclerodermus waps, and their diversities and functions were also predicted. Results: The three most prevalent phyla of microorganisms in the sample were Firmicutes, Bacteroides, and Proteus. The KEEG pathways prediction results indicated that the three pathways with the highest relative abundances in the S. sichuanensis species were translation, membrane transport, and nucleotide metabolism. These pathways differed from those observed in S. guani, S. pupariae, and S. alternatusi, which exhibited carbohydrate metabolism, membrane transport, and amino acid metabolism, respectively. Bacteroides were found to be abundant in several species, whereas Wolbachia was the most abundant among S. sichuanensis, with a significant negative correlation between temperature and carriage rate. Conclusions: These results offer insights into the microbial communities associated with the bethylid wasps, which is crucial for understanding how to increase the reproductive capacity of wasps, enhance their parasitic effects, and lower cost in biocontrol.


Subject(s)
RNA, Ribosomal, 16S , Symbiosis , Wasps , Animals , Wasps/microbiology , Wasps/physiology , China , RNA, Ribosomal, 16S/genetics , High-Throughput Nucleotide Sequencing , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Biological Control Agents , Coleoptera/microbiology , Phylogeny , Microbiota , Bacteroides/genetics , Bacteroides/isolation & purification , Bacteroides/classification , Firmicutes/genetics , Firmicutes/isolation & purification , Firmicutes/classification , Wolbachia/genetics , Wolbachia/isolation & purification , Wolbachia/classification , Wolbachia/physiology , Biodiversity
2.
FEMS Microbiol Ecol ; 100(7)2024 Jun 17.
Article in English | MEDLINE | ID: mdl-38794902

ABSTRACT

Mucin is a glycoprotein secreted throughout the mammalian gastrointestinal tract that can support endogenous microorganisms in the absence of complex polysaccharides. While several mucin-degrading bacteria have been identified, the interindividual differences in microbial communities capable of metabolizing this complex polymer are not well described. To determine whether community assembly on mucin is deterministic across individuals or whether taxonomically distinct but functionally similar mucin-degrading communities are selected across fecal inocula, we used a 10-day in vitro sequential batch culture fermentation from three human donors with mucin as the sole carbon source. For each donor, 16S rRNA gene amplicon sequencing was used to characterize microbial community succession, and the short-chain fatty acid profile was determined from the final community. All three communities reached a steady-state by day 7 in which the community composition stabilized. Taxonomic comparisons amongst communities revealed that one of the final communities had Desulfovibrio, another had Akkermansia, and all three shared other members, such as Bacteroides. Metabolic output differences were most notable for one of the donor's communities, with significantly less production of acetate and propionate than the other two communities. These findings demonstrate the feasibility of developing stable mucin-degrading communities with shared and unique taxa. Furthermore, the mechanisms and efficiencies of mucin degradation across individuals are important for understanding how this community-level process impacts human health.


Subject(s)
Feces , Fermentation , Microbial Consortia , Mucins , RNA, Ribosomal, 16S , Humans , Mucins/metabolism , RNA, Ribosomal, 16S/genetics , Feces/microbiology , Bacteria/metabolism , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Fatty Acids, Volatile/metabolism , Gastrointestinal Microbiome , Akkermansia/metabolism , Desulfovibrio/metabolism , Desulfovibrio/genetics , Desulfovibrio/classification , Bacteroides/metabolism , Bacteroides/genetics , Bacteroides/classification , Bacteroides/growth & development
3.
Article in English | WPRIM (Western Pacific) | ID: wpr-66143

ABSTRACT

BACKGROUND: Bacteroides fragilis group organisms are the most frequently isolated anaerobes in human infections. Increasing resistance to various antimicrobial agents is a significant problem in choosing appropriate antimicrobial agents to treat anaerobic infections. Periodic monitoring of the regional resistance trends of B. fragilis group isolates is needed. METHODS: A total of 466 nonduplicate clinical isolates of B. fragilis group organisms (276 B. fragilis, 106 Bacteroides thetaiotaomicron, and 84 other B. fragilis group organisms) were collected during the 8-yr period from 1997 to 2004 in a Korean university hospital. Minimum inhibitory concentrations to various antimicrobial agents were determined by the CLSI agar dilution method. RESULTS: Eight isolates were resistant to imipenem. Additionally, the resistance rates to cefotetan were decreased in B. thetaiotaomicron, while those for clindamycin were significantly increased compared to the rates found in previous studies. Depending on species, resistance rates were 1-4% for imipenem, 1-6% for piperacillin-tazobactam, 4-11% for cefoxitin, 33-49% for piperacillin, 14-60% for cefotetan, and 51-76% for clindamycin. No isolates were resistant to chloramphenicol or metronidazole. CONCLUSIONS: Piperacillin-tazobactam, cefoxitin, imipenem, chloramphenicol, and metronidazole are still active against B. fragilis group isolates, while clindamycin no longer has a value as an empirical therapeutic agent in Korea. Furthermore, this study identified the first imipenem-resistant B. fragilis group isolates in Korea.


Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Bacteroides/classification , Bacteroides fragilis/drug effects , Cefoxitin/pharmacology , Chloramphenicol/pharmacology , Drug Resistance, Multiple, Bacterial , Imipenem/pharmacology , Metronidazole/pharmacology , Microbial Sensitivity Tests , Penicillanic Acid/analogs & derivatives , Piperacillin/pharmacology , Republic of Korea
SELECTION OF CITATIONS
SEARCH DETAIL